Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neoplasm, Residual × atezolizumab × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 27 Triple Negative Breast Neoplasms 13 Carcinoma, Transitional Cell 12 Breast Neoplasms 12 Urinary Bladder Neoplasms 11 Small Cell Lung Carcinoma 10 Neoplasms 8 Melanoma 8 Carcinoma, Hepatocellular 6 Neoplasm Metastasis 5 Lung Neoplasms 5 Uterine Cervical Neoplasms 4 Ovarian Neoplasms 4 Lymphoma 4 Colorectal Neoplasms 4 Carcinoma, Renal Cell 4 Recurrence 3 Lymphoma, Follicular 3 Leukemia, Myeloid, Acute 3 Brain Neoplasms 3 Solid Tumors 2 Prostatic Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Fallopian Tube Neoplasms 2 Cholangiocarcinoma 2 Carcinoma 2 Biliary Tract Neoplasms 2 Uterine Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1

Interventions

Rituximab 4 blinatumomab 3 Whole-Body Irradiation 2 Lenalidomide 2 Cyclophosphamide 2 Clofarabine 2 treosulfan 1 thymoglobulin 1 sabatolimab 1 peginterferon alfa-2a 1 obinutuzumab 1 midostaurin 1 ixazomib 1 fludarabine phosphate 1 fludarabine 1 eribulin 1 daratumumab 1 acalabrutinib 1 Trastuzumab 1 Tacrolimus 1 Sodium Chloride 1 Peripheral Blood Stem Cell Transplantation 1 Pentostatin 1 N,N-dicyclohexyl-isoborneol-10-sulfonamide 1 Mycophenolic Acid 1 Methotrexate 1 Melphalan 1 Magnetic Resonance Imaging 1 Imatinib Mesylate 1 Histamine Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡